Abstract
The inconvenience and pain of hospital-based photodynamic therapy (PDT) is sometimes limiting.1 We developed very low irradiance LEDs for ambulatory PDT. Preliminary studies showed this to be convenient and relatively painless.1-4 Here we evaluate the Ambulight® device (Ambicare Health Ltd) in a randomised controlled assessor-blinded study comparing low irradiance ambulatory PDT (APDT) with conventional PDT (CPDT) for superficial basal cell carcinoma (SBCC) and Bowen's disease (BD) (lesions ≤2cm).
| Original language | English |
|---|---|
| Article number | 20762 |
| Number of pages | 3 |
| Journal | British Journal of Dermatology |
| Volume | Early View |
| Early online date | 24 Nov 2021 |
| DOIs | |
| Publication status | E-pub ahead of print - 24 Nov 2021 |
Access to Document
- Ibbotson_2021_BJD_Randomised-assessor_AAM
Copyright © 2021 British Association of Dermatologists. This work has been made available online in accordance with publisher policies or with permission. Permission for further reuse of this content should be sought from the publisher or the rights holder. This is the author created accepted manuscript following peer review and may differ slightly from the final published version. The final published version of this work is available at https://doi.org/10.1111/bjd.20762.